[go: up one dir, main page]

GB0720444D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0720444D0
GB0720444D0 GB0720444A GB0720444A GB0720444D0 GB 0720444 D0 GB0720444 D0 GB 0720444D0 GB 0720444 A GB0720444 A GB 0720444A GB 0720444 A GB0720444 A GB 0720444A GB 0720444 D0 GB0720444 D0 GB 0720444D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0720444A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0720444A priority Critical patent/GB0720444D0/en
Publication of GB0720444D0 publication Critical patent/GB0720444D0/en
Priority to PCT/EP2008/063950 priority patent/WO2009050227A1/fr
Ceased legal-status Critical Current

Links

GB0720444A 2007-10-18 2007-10-18 Novel compounds Ceased GB0720444D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0720444A GB0720444D0 (en) 2007-10-18 2007-10-18 Novel compounds
PCT/EP2008/063950 WO2009050227A1 (fr) 2007-10-18 2008-10-16 Dérivés de pyridazine pour inhiber la production de peptide béta amyloïde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0720444A GB0720444D0 (en) 2007-10-18 2007-10-18 Novel compounds

Publications (1)

Publication Number Publication Date
GB0720444D0 true GB0720444D0 (en) 2007-11-28

Family

ID=38814093

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0720444A Ceased GB0720444D0 (en) 2007-10-18 2007-10-18 Novel compounds

Country Status (2)

Country Link
GB (1) GB0720444D0 (fr)
WO (1) WO2009050227A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010211109B2 (en) 2009-02-06 2014-11-27 Cellzome Limited Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
CA2778517A1 (fr) 2009-07-15 2011-01-20 Janssen Pharmaceuticals, Inc. Derives de triazole et d'imidazole substitues en tant que modulateurs de gamma secretase
PH12012501381A1 (en) 2010-01-15 2012-10-22 Janssen Pharmaceuticals Inc Novel substituted bicyclic triazole derivatives as gamma secretase modulators
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2585455B1 (fr) 2010-06-24 2019-08-07 The Regents of the University of California Composés et leurs utilisations dans la modulation des niveaux de différentes alloformes du peptide amyloïde bêta
MX2013010970A (es) 2011-03-24 2013-10-17 Cellzome Ltd Novedosos derivados de triazolil piperazina y triazolil piperidina sustituidos como moduladores de gamma-secretasa.
ES2602794T3 (es) 2011-03-31 2017-02-22 Pfizer Inc Piridinonas bicíclicas novedosas
EA023045B1 (ru) 2011-07-15 2016-04-29 Янссен Фармасьютикалз, Инк. Новые замещенные производные индола в качестве модуляторов гамма-секретазы
MX355164B (es) 2012-05-16 2018-04-06 Janssen Pharmaceuticals Inc Derivados de 3,4-dihidro-2h-pirido[1,2-a]pirazin-1,6-diona sustituidos utiles para el tratamiento de la enfermedad de alzheimer (inter alia).
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
ES2608356T3 (es) 2012-12-20 2017-04-10 Janssen Pharmaceutica Nv Novedosos derivados tricíclicos de 3,4-dihidro-2H-pirido[1,2-a]pirazin-1,6-diona como moduladores de la secretasa gamma
AU2014206834B2 (en) 2013-01-17 2017-06-22 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US9938263B2 (en) 2013-03-12 2018-04-10 The General Hospital Corporation Gamma-secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
EP3212633B1 (fr) 2014-10-31 2019-12-04 The General Hospital Corporation Puissants modulateurs de la sécrétase gamma
WO2016100184A1 (fr) 2014-12-16 2016-06-23 Forum Pharmaceuticals, Inc. Composés amide de quinuclidine à substituants géminal, en tant qu'agonistes des récepteurs nicotiniques de l'acétylcholine α7
MX368391B (es) 2015-02-03 2019-09-30 Pfizer Ciclopropabenzofuranil-piridopirazindionas novedosas.
WO2016201096A1 (fr) 2015-06-10 2016-12-15 Forum Pharmaceuticals, Inc. Composés d'aminobenzisoxazole en tant qu'agonistes des récepteurs de l'acétylcholine α7-nicotinique
WO2017027600A1 (fr) 2015-08-12 2017-02-16 Forum Pharmaceuticals, Inc. Composés d'aminobenzisoxazole à substitution géminale utilisés en tant qu'agonistes de récepteurs de l'acétylcholine α7-nicotinique
JP7569688B2 (ja) 2017-12-22 2024-10-18 ハイバーセル,インコーポレイテッド ホスファチジルイノシトールリン酸キナーゼ阻害剤としてのアミノピリジン誘導体
AR119731A1 (es) * 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
CN111732544B (zh) * 2020-06-23 2022-03-11 上药康丽(常州)药业有限公司 一种合成3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的方法
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
UY40374A (es) 2022-08-03 2024-02-15 Novartis Ag Inhibidores de inflamasoma nlrp3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395844A (en) * 1993-06-10 1995-03-07 The Du Pont Merck Pharmaceutical Company Imidazole 5-position substituted angiotensin II antagonists
DE602005017033D1 (de) * 2004-06-16 2009-11-19 Wyeth Corp Amino-5,5-diphenylimidazolon-derivate zur beta-sekretase-hemmung

Also Published As

Publication number Publication date
WO2009050227A1 (fr) 2009-04-23

Similar Documents

Publication Publication Date Title
GB0710528D0 (en) Novel compounds
EP2146745A4 (fr) Nouveaux composés
EP2152081A4 (fr) Nouveaux composés
GB0712888D0 (en) Novel compounds
GB0720444D0 (en) Novel compounds
GB0705882D0 (en) Novel compounds
GB0710865D0 (en) Novel compounds
GB0706630D0 (en) Novel compounds
GB0705803D0 (en) Novel compounds
GB0708858D0 (en) Novel compounds
GB0710863D0 (en) Novel compounds
GB0711521D0 (en) Novel compounds
GB0703973D0 (en) Novel compounds
GB0712392D0 (en) Novel compounds
GB0701638D0 (en) Novel compounds
GB0700992D0 (en) Novel compounds
GB0703404D0 (en) Novel compounds
GB0703631D0 (en) Novel compounds
GB0703397D0 (en) Novel compounds
GB0712887D0 (en) Novel compounds
GB0712886D0 (en) Novel compounds
GB0703677D0 (en) Novel compounds
GB0712885D0 (en) Novel compounds
GB0712865D0 (en) Novel compounds
GB0703387D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)